These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 8370372)

  • 1. Haemodynamic and clinical effects of an intravenous potassium channel opener--a review.
    Kato K
    Eur Heart J; 1993 Jul; 14 Suppl B():40-7. PubMed ID: 8370372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coronary haemodynamics and vasodilatory profile of a potassium channel opener in patients with coronary artery disease.
    Suryapranata H
    Eur Heart J; 1993 Jul; 14 Suppl B():16-21. PubMed ID: 8370366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A double-blind comparison of the long-term efficacy of a potassium channel opener and a calcium antagonist in stable angina pectoris.
    Guermonprez JL; Blin P; Peterlongo F
    Eur Heart J; 1993 Jul; 14 Suppl B():30-4. PubMed ID: 8370370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nicorandil and cardiovascular performance in patients with coronary artery disease.
    Suryapranata H; MacLeod D
    J Cardiovasc Pharmacol; 1992; 20 Suppl 3():S45-51. PubMed ID: 1282175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nitrate tolerance: comparison of nicorandil, isosorbide dinitrate, and nitroglycerin in anesthetized dogs.
    Sakai K; Kuromaru O
    J Cardiovasc Pharmacol; 1987; 10 Suppl 8():S17-24. PubMed ID: 2447420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the degree of hemodynamic tolerance during intravenous infusion of nitroglycerin versus nicorandil in patients with congestive heart failure.
    Larsen AI; Gøransson L; Aarsland T; Tamby JF; Dickstein K
    Am Heart J; 1997 Sep; 134(3):435-41. PubMed ID: 9327699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of the new nitrate ester ITF 296 on coronary and systemic hemodynamics in the conscious dog: comparison with nitroglycerin and nicorandil.
    Ueno A; Bergamaschi M; Gromo G; Nonaka K; Mizrahi J
    J Cardiovasc Pharmacol; 1995; 26 Suppl 4():S13-20. PubMed ID: 8839221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antianginal and anti-ischemic efficacy of nicorandil in comparison with isosorbide-5-mononitrate and isosorbide dinitrate: results from two multicenter, double-blind, randomized studies with stable coronary heart disease patients.
    Döring G
    J Cardiovasc Pharmacol; 1992; 20 Suppl 3():S74-81. PubMed ID: 1282180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of nicorandil on coronary circulation in patients with ischemic heart disease: comparison with nitroglycerin.
    Aizawa T; Ogasawara K; Kato K
    J Cardiovasc Pharmacol; 1987; 10 Suppl 8():S123-9. PubMed ID: 2447419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A potassium channel opener as monotherapy in chronic stable angina pectoris: comparison with placebo.
    Why HJ; Richardson PJ
    Eur Heart J; 1993 Jul; 14 Suppl B():25-9. PubMed ID: 8370369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular effects of isosorbide dinitrate infused intravenously into anaesthetized dogs.
    Kuromaru O; Sakai K
    Clin Exp Pharmacol Physiol; 1986 Aug; 13(8):619-28. PubMed ID: 2947766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antianginal and anti-ischemic efficacy of nicorandil compared with nifedipine in patients with angina pectoris and coronary heart disease: a double-blind, randomized, multicenter study.
    Ulvenstam G; Diderholm E; Frithz G; Gudbrandsson T; Hedbäck B; Höglund C; Moelstad P; Perk J; Sverrisson JT
    J Cardiovasc Pharmacol; 1992; 20 Suppl 3():S67-73. PubMed ID: 1282179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of nicorandil on coronary hemodynamics in ischemic heart disease: comparison with nitroglycerin, nifedipine, and propranolol.
    Kobayashi K; Hakuta T
    J Cardiovasc Pharmacol; 1987; 10 Suppl 8():S109-15. PubMed ID: 2447417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tolerance to the increase in coronary blood flow induced by KRN2391.
    Kaneta S; Jinno Y; Harada K; Fukushima H; Ogawa N
    Arch Int Pharmacodyn Ther; 1992; 318():21-35. PubMed ID: 1463369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of intravenous nicorandil on coronary circulation in humans: plasma concentration and action mechanism.
    Nakae I; Matsumoto T; Horie H; Yokohama H; Omura T; Minai K; Matsui T; Nozawa M; Takahashi M; Sugimoto Y; Ito M; Izumi M; Nakamura Y; Mitsunami K; Kinoshita M
    J Cardiovasc Pharmacol; 2000 Jun; 35(6):919-25. PubMed ID: 10836727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effective and safe dose of intracoronary nicorandil in man.
    Miwa K; Igawa A; Yamanishi K; Fujita M; Inouc H
    Jpn Circ J; 1995 Nov; 59(11):736-44. PubMed ID: 8747763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative study on the effects of intracoronary nicorandil and nitroglycerin in ischaemic, reperfused porcine hearts.
    Klein HH; Pich S; Lindert-Heimberg S; Schade-Brittinger C; Maisch B; Nebendahl K
    Eur Heart J; 1995 May; 16(5):603-9. PubMed ID: 7588890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of development of tolerance between nicorandil and nitroglycerin in anesthetized, open-chest dogs.
    Kuromaru O; Sakai K
    Jpn J Pharmacol; 1986 Oct; 42(2):199-208. PubMed ID: 2948042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selected issues from an overview on nicorandil: tolerance, duration of action, and long-term efficacy.
    Wagner G
    J Cardiovasc Pharmacol; 1992; 20 Suppl 3():S86-92. PubMed ID: 1282183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of nicorandil, an antianginal potassium channel opener, on left ventricular systolic and diastolic function in patients with chronic coronary artery disease.
    Murayama S; Yamakado T; Nakano T
    Am J Cardiol; 1997 Jun; 79(12):1685-9. PubMed ID: 9202366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.